Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CV
CV logo

CV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy CapsoVision Inc (CV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.670
1 Day change
-14.22%
52 Week Range
15.370
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CapsoVision Inc (CV) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The technical picture is mildly constructive, but there is no clear catalyst, no recent news, no valuation support, and no proprietary buy signal. My direct view is to hold off for now rather than buy immediately.

Technical Analysis

CV is showing a mixed-to-slightly bullish technical setup. The MACD histogram is positive at 0.0511 but contracting, which suggests momentum is not accelerating. RSI_6 at 54.459 is neutral and does not indicate oversold conditions or strong upside pressure. The moving averages are bullish with SMA_5 > SMA_20 > SMA_200, which supports the broader trend. Price at 7.27 is just above the pivot of 7.069 and below resistance at R1 7.615, so the stock is in the middle of a range with limited confirmation of a breakout. Short-term pattern stats also look modest, with only slight expected upside over the next week and month.

Positive Catalysts

  • Bullish moving average structure (SMA_5 > SMA_20 > SMA_200). Price is holding above the pivot level. MACD remains above zero, which keeps the trend from turning bearish. No recent negative news was reported, which avoids an immediate sentiment drag.

Neutral/Negative Catalysts

  • No news in the recent week means there is no fresh catalyst to drive re-rating. Hedge funds are neutral with no significant activity last quarter, and insiders are also neutral with no meaningful buying support. AI Stock Picker has no signal today, SwingMax has no recent signal, and there is no congress trading data. The financial snapshot is unavailable, so there is no latest-quarter growth evidence to support a long-term entry.

Financial Performance

Latest quarter financial data was not available because the financial snapshot returned an error. As a result, there is no usable evidence here on revenue, earnings, or growth trends for the most recent quarter season.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so the recent Wall Street view cannot be confirmed from the dataset. Based on the available information, pros appear neutral to slightly constructive because the chart is above key moving averages, while cons dominate due to the lack of analyst support, lack of news catalysts, and absent valuation data.

Wall Street analysts forecast CV stock price to rise
2 Analyst Rating
Wall Street analysts forecast CV stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 6.610
sliders
Low
7
Averages
10.5
High
14
Current: 6.610
sliders
Low
7
Averages
10.5
High
14
Benchmark
Bruce Jackson
Speculative Buy
downgrade
$14 -> $10
AI Analysis
2026-03-27
Reason
Benchmark
Bruce Jackson
Price Target
$14 -> $10
AI Analysis
2026-03-27
downgrade
Speculative Buy
Reason
Benchmark analyst Bruce Jackson lowered the firm's price target on CapsoVision to $10 from $14 and keeps a Speculative Buy rating on the shares after the company reported Q4 results and provided a business update. Afterwards, the firm's new 2026 revenue estimate is $15.8M, down from $19.7M, and its new 2027 revenue estimate is $23.3M, which it notes assumes a launch of CapsoCam Colon in the second half of 2027.
Roth Capital
Buy
upgrade
$7 -> $11
2026-03-24
Reason
Roth Capital
Price Target
$7 -> $11
2026-03-24
upgrade
Buy
Reason
Roth Capital raised the firm's price target on CapsoVision to $11 from $7 and keeps a Buy rating on the shares after its Q4 pre-announcement and the closing of a $14M private placement. Proceeds from the financing are expected to support general corporate purposes, including R&D, sales and marketing, and working capital, with a focus on advancing key pipeline programs and AI capabilities, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CV
Unlock Now

People Also Watch